Comparative Effectiveness Research to Improve the Health of Sexual and Gender Minority Patients Through Cultural Competence and Skill Training of Community Health Center Providers and Non-clinical Staff (PCORI-SOGI)

August 23, 2023 updated by: Kenneth H. Mayer, MD, Fenway Community Health
The primary goal of this PCORI proposal is to evaluate the impact of enhanced provider and clinical staff training to address the health disparities of SGM CHC patients to ultimately improve their health outcomes because CHCs are a key part of the U.S. health care delivery system for underserved populations. The current application proposes to test an intervention designed to understand how CHCs, including front line staff and safety net clinical providers, can identify and provide optimal care for their SGM patients, and will determine whether enhanced training of CHC staff in best practices for the provision of primary care for SGM patients will improve their clinical outcomes. The time is right for routinization of SOGI measures in EHRs and evaluation of the optimal methods to train primary care providers in the best practices for the care of SGM patients.

Study Overview

Detailed Description

This project will work with 12 community health centers across the country that are part of and extended from the HRSA-established Community Health Applied Research Network (CHARN) to determine the optimal way to train CHC staff in the collection of SOGI data, and will evaluate the impact of enhanced SOGI data collection on health outcomes for LGBT patients. The project will build on more than six years of collaborations of a network of safety-net CHCs, including patient investigators from the inception of the project, with a plan for ongoing local patient engagement. Aim 1: Conduct interviews with patient and clinical stakeholders regarding how SOGI data are being used to inform patient care, and how they feel SOGI data should best be collected and utilized. Aim 2: Educate providers in culturally competent patient-centered care with sexual and gender minority populations. Aim 3: Compare the effect of a SOGI educational training program to usual practice on SOGI documentation rates and appropriate screening rates for LGBT patients.

The project will determine the optimal way to train CHC staff in the collection of SOGI data, and will evaluate the impact of enhanced SOGI data collection on health outcomes for LGBT patients. The project team proposes a study design that is commonly employed to examine changes in outcomes (e.g., screening rates) across time, comparing rates prior to and after the educational training intervention. The project will measure the impact of changes to practice and to patient outcomes (e.g., depression screening, appropriate use of mammography and HPV screening for lesbians and transgender women), as well as patient satisfaction.

Results of this study would be the first of their kind to evaluate the impact of a series of educational programs on the healthcare outcomes of LGBT patients and could provide a replicable patient-centered model for routinely collecting and documenting sexual and gender minority information at CHCs and improving provider competence in care. Ultimately, the study has strong potential for improving the quality of care for sexual and gender minorities and reducing health disparities.

Study Type

Interventional

Enrollment (Actual)

12

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Boston, Massachusetts, United States, 02115
        • Fenway Community Health Cetner

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • 18 years or older
  • Clinical staff or patient at participating clinical site (for staff interviews and web surveys)
  • English speakers

Exclusion Criteria:

  • Does not meet the inclusion criteria above

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control/Usual Care
  • Readiness Assessment (web survey for CHC leadership and providers)
  • Patient web surveys (10 total per site; 5 SGM and 5 cisgendered)
  • Option to view 60 minute online webinar "Do Ask, Do Tell: Collecting Data on Sexual Orientation and Gender Identity at Health Centers"
Active Comparator: Intervention
  • Readiness Assessment (web survey for CHC leadership and providers)
  • Patient web surveys (10 total per site; 5 SGM and 5 cisgendered)
  • CHC staff leadership key informant interviews (up to 5 at each site)
  • Tailored Educational Clinician and Non-clinician staff training intervention and technical assistance follow-up
An optimized training program for non-clinical staff, clinicians and administrators developed by TFI's National LGBT Health Education Center that will include content-specific webinars and "Office Hours" for specific CHC consultations to optimize the provision of SGM health services at each CHC and to foster the development of in-house expertise to sustain ongoing training and quality improvement in the provision of care for LGBT patients.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sexual Orientation and Gender Identity (SOGI) status
Time Frame: 24 month follow up period
% of patients at CHC with SOGI status documented
24 month follow up period
Behavioral Health and Substance Use Assessment
Time Frame: 24 month follow up period
Documentation of PHQ9
24 month follow up period
Behavioral Health and Substance Use Assessment
Time Frame: 24 month follow up period
Documentation of AUDIT
24 month follow up period
Behavioral Health and Substance Use Assessment
Time Frame: 24 month follow up period
Documentation of tobacco status
24 month follow up period
Vital Sign
Time Frame: 24 month follow up period
Documentation of weight or BMI
24 month follow up period
Vaccination
Time Frame: 24 month follow up period
Documentation of Hepatitis A vaccination
24 month follow up period
Vaccination
Time Frame: 24 month follow up period
Documentation of Hepatitis B vaccination
24 month follow up period
Mammography
Time Frame: 24 month follow up period
Documentation of mammogram
24 month follow up period
Cervical PAP
Time Frame: 24 month follow up period
Documentation of PAP
24 month follow up period

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Behavioral health referral, if problem identified
Time Frame: 24 month follow up period
Documentation of referral among those where a behavioral health problem is identified
24 month follow up period
Tobacco counselling referral, if smoker
Time Frame: 24 month follow up period
Documentation of referral among current smokers
24 month follow up period
Weight control referral, if problem identified
Time Frame: 24 month follow up period
Documentation of referral among those where a weight problem is identified
24 month follow up period
HIV screening
Time Frame: 24 month follow up period
% of patients at CHC with HIV screening
24 month follow up period
Bacterial STI screening
Time Frame: 24 month follow up period
% of patients at CHC with STI screening
24 month follow up period
Anal cancer
Time Frame: 24 month follow up period
% of patients at CHC with anal PAP screening
24 month follow up period

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient satisfaction rates
Time Frame: 39 month study period
Measured through pre- and post-intervention patient web surveys
39 month study period
Patient service utilization
Time Frame: 24 month follow up period
Measured through annual data reports from participating sites
24 month follow up period

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2018

Primary Completion (Actual)

June 30, 2022

Study Completion (Actual)

May 31, 2023

Study Registration Dates

First Submitted

May 14, 2018

First Submitted That Met QC Criteria

May 31, 2018

First Posted (Actual)

June 13, 2018

Study Record Updates

Last Update Posted (Actual)

August 25, 2023

Last Update Submitted That Met QC Criteria

August 23, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 6271

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Education

Clinical Trials on Clinician and Non-clinician staff training

Subscribe